What is adenomyomatosis of the gallbladder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adenomyomatosis of the Gallbladder

Adenomyomatosis of the gallbladder is a benign, degenerative condition characterized by mural hyperplasia with epithelial proliferation and hypertrophy of the muscularis propria, resulting in outpouchings of mucosa called Rokitansky-Aschoff sinuses. 1

Definition and Pathophysiology

  • Adenomyomatosis is defined as mural hyperplasia that may be diffuse, focal, or segmental with characteristic imaging findings including comet-tail artifacts (on grayscale imaging) or twinkling artifacts (on color Doppler imaging) due to intramural cholesterol crystals 2
  • The condition involves excessive epithelial proliferation with hypertrophy of the muscular layer, leading to mucosal invaginations through the thickened muscularis forming intramural diverticula known as Rokitansky-Aschoff sinuses 1, 3
  • The pathogenesis remains unknown, though chronic inflammation of the gallbladder is considered a necessary precursor 4

Classification

  • Three distinct morphological types are recognized 1:
    • Fundal: Focal thickening involving only the gallbladder fundus
    • Segmental: Circumferential wall overgrowth leading to compartmentalization
    • Diffuse: Disseminated thickening and irregularity throughout the mucosa and muscularis

Epidemiology

  • Adenomyomatosis commonly occurs in middle-aged individuals with equal sex distribution 1
  • Prevalence in cholecystectomy specimens ranges from 1% to 9%, with incidence increasing after age 50 4
  • The condition can occur rarely in children, as documented in pediatric case reports 3

Clinical Presentation

  • Most patients with adenomyomatosis remain asymptomatic, with the condition often discovered incidentally during imaging for other reasons 5
  • When symptomatic, patients typically present with:
    • Right upper quadrant pain or dull discomfort 6
    • Hepatic colic, even in the absence of gallstones 4
    • Rarely, acute acalculous cholecystitis 4
  • Gallstones are commonly associated (50-90% of cases) but not necessary for symptom development 4

Diagnosis

  • Ultrasound is the initial imaging modality of choice 7, with characteristic findings including:
    • Thickened gallbladder wall containing small cystic spaces (Rokitansky-Aschoff sinuses)
    • "Comet-tail" artifacts on grayscale imaging 2, 1
    • "Twinkling" artifacts on color Doppler imaging 2, 1
  • If differentiation between tumefactive sludge and adenomyomatosis is challenging:
    • Short-interval follow-up ultrasound within 1-2 months with optimized technique is recommended 8
    • Higher sensitivity Doppler techniques such as power Doppler and B-Flow may help differentiate 2
  • Advanced imaging options when uncertainty persists:
    • Contrast-enhanced ultrasound (CEUS) can distinguish vascular lesions from sludge 7, 8
    • MRI with cholangiography sequences shows characteristic "pearl-necklace sign" and has extremely high sensitivity for identifying Rokitansky-Aschoff sinuses 7, 1
    • CT is less accurate than CEUS or MRI but may show a "rosary sign" 8, 1

Management

Symptomatic Adenomyomatosis

  • Cholecystectomy is the recommended treatment for symptomatic adenomyomatosis of any type, with laparoscopic approach being the standard of care 7, 4
  • Surgical risk is minimal with cholecystectomy, with morbidity of 2-8% 7, 8
  • Risk of bile duct injury during cholecystectomy is approximately 0.3-0.6% 7, 8
  • Cholecystectomy results in complete resolution of symptoms 4

Asymptomatic Adenomyomatosis

  • Management depends on the type of adenomyomatosis 1:
    • Fundal type: Can be safely observed with ultrasound
    • Segmental type: Cholecystectomy may be considered due to increased risk of malignancy
    • Diffuse type: Cholecystectomy may be considered due to difficulty visualizing any coexisting malignancy
  • The Society of Radiologists in Ultrasound (SRU) consensus suggests that extended follow-up beyond 3 years is not productive 7, 8

Relationship to Malignancy

  • While adenomyomatosis is generally benign, there are rare associations with dysplastic changes and cancer, particularly in the context of chronic inflammation and lithiasis 3
  • In cases of diagnostic doubt regarding possible malignancy, cholecystectomy is justified 4
  • The segmental type carries a higher risk of malignancy compared to other types 1

Special Considerations

  • For pregnant patients with symptomatic adenomyomatosis:
    • Laparoscopic cholecystectomy is safe during pregnancy regardless of trimester, ideally performed in the second trimester 7
    • For late third-trimester presentations, postponing surgery until after delivery may be reasonable if it doesn't pose risk to maternal or fetal health 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diffuse Adenomyomatosis of the Gallbladder in a Child.

Journal of pediatric hematology/oncology, 2016

Research

Gallbladder adenomyomatosis: Diagnosis and management.

Journal of visceral surgery, 2017

Research

[Diffuse adenomyomatosis of the gallbladder].

Acta chirurgica Iugoslavica, 1990

Guideline

Management of Gallbladder Adenomyomatosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment of Adenomyomatosis of the Gallbladder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.